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Introduction
Andersen-Tawil syndrome is an autosomal dominant heritable 
disorder associated with a triad of symptoms: periodic paralysis, 
ECG changes and characteristic dysmorphic features.1 Although 
the genetic cause remains enigmatic in some patients, approxi-
mately 60% have been found to have loss of function mutations 
in KCNJ2, the gene which encodes the inwardly rectifying K+ 
(Kir) pore forming subunit, Kir2.1. This subunit contributes to 
the inwardly rectifying K+ current (I
K1
) found in cardiac and a 
wide variety of other cells.2
Although originally identified based on unusual rectifica-
tion properties and large inward currents at hyperpolarized 
membrane potentials, inwardly rectifying channels exhibit 
a smaller, but physiologically crucial, conductance in the 
more depolarized range of membrane voltages from -80 to 
-40 mV. In this range, the current plays a role in modulat-
ing resting membrane potentials and in shaping the terminal 
phase of action potential repolarization.3 Due to these roles, 
alterations in I
K1
 amplitudes, densities, and/or properties may 
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stabilize re-entrant malignant arrhythmias such as ventricular 
fibrillation.3
The channels underlying I
K1
 are tetramers of Kir2.x subunits.1 
Kir2.1 (encoded by the KCNJ2 gene) appears to be an essential 
subunit in ventricular myocytes and Kir2.2 also contributes to 
I
K1
.4 The role(s) of Kir2.3 and 2.4 in cardiac tissue remains less 
well defined although they have been shown to form heterotetra-
mers with Kir2.1 and/or Kir2.2.5,6 Channel function is strongly 
dependent on the membrane-associated second messenger phos-
photidylinositolbisphosphate (PIP
2
), and outward currents are 
blocked by positively charged intracellular species, most notably 
polyamines, such as spermine, spermidine and putrescine, and by 
magnesium ions, thereby generating the property of inward recti-
fication.1 One intriguing region of the Kir α subunit is the “slide 
helix” which is predicted to form an alpha helix lying parallel to 
the cell membrane between the transmembrane and cytoplasmic 
domains.7,8 Several Andersen-Tawil syndrome associated muta-
tions have been identified in this region and suggested to disrupt 
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ventricular myocyte model predict that the reduction in I
K1
 
resulting from the presence of the D71Y mutation will result in 
prolongation of the terminal portion of the action potential and 
altered cellular excitability.
Results
Patient presentation. In 2009, a 28-year-old Caucasian male 
was admitted for further evaluation of periodic paralysis. His 
symptoms started in January 2005 and resulted in four hospi-
talizations due to severe muscular weakness. Pertinent findings 
on examination included bilateral syndactyly of toes 2–3 and 
ECG tracings revealed frequent premature ventricular complexes 
and bigeminy (Fig. 1A). Although the QTc interval was within 
normal limits, there were prominent U-waves on the ECG. In 
light of these combined findings, Andersen-Tawil syndrome was 
suspected. The KCNJ2 gene (encoding Kir2.1) was sequenced, 
revealing a heterozygous, single guanine to thymine base pair 
change at position 211 (G211T) resulting in a single aspartic acid 
to tyrosine substitution at position 71 (D71Y). Figure 1B shows 
the overall structure of the Kir2.1 subunit and Figure 1C illus-
trates the slide helix region in more detail.
Kir2.1-D71Y mutation results in a non-functional 
channel. To assess the functional consequences of the 
Mutations in Kir2.1 have been associated with multiple 
 cardiac electrical diseases, including catecholaminergic polymor-
phic ventricular tachycardia (CPVT), familial atrial fibrillation, 
short QT syndrome and Andersen-Tawil syndrome (also called 
long QT syndrome 7).1 To date, 33 loss of function mutations 
in KCNJ2 have been associated with Andersen-Tawil syndrome.1 
Loss of function mutations are located throughout the protein 
and have been identified in the pore-forming domain, the PIP
2
 
binding domain, the slide helix and regions involved in protein 
trafficking.10
We report here the identification of a novel KCNJ2 mutation in 
a patient with Andersen-Tawil syndrome. In this patient, a single 
base pair mutation (G211T) results in a D71Y substitution in the 
slide helix region of Kir2.1. Heterologous expression experiments 
demonstrate that the mutant subunit fails to form functional 
Kir channels when expressed alone, but suppress Kir2.1-encoded 
currents when co-expressed with wild-type Kir2.1 subunits. 
Co-expression of the mutant subunit, however, does not appear 
to impair membrane localization of wild-type Kir2.1 subunits or 
affect the time- or voltage-dependent properties of the currents. 
Additional experiments demonstrate that expression of hKir2.1-
D71Y in mouse neonatal cardiomyocytes suppresses inwardly 
rectifying currents (I
K1
), consistent with a functional impact of 
this mutation on native cardiac I
K1
. Simulations using a human 
Figure 1. (A) Twelve-lead ECG from the patient demonstrates frequent ventricular ectopy (arrow) and prominent U waves (arrowhead). (B) Predicted 
 structure of Kir2.1 with two subunits of the tetramer removed for clarity. The ion selective pore, slide helix and N- and C-termini are indicated. (C) The 
slide helix region is shown in greater detail. Colored residues of the slide helix indicate amino acids with hydrophobic side chains (yellow), hydrophilic 
side chains (green), and the location of the D71Y mutation (red). Structure is based on the KirBac1.1 channel (PBD ID: 1P7B) and rendered using the 
PyMOL Molecular Graphics System.25
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investigated the consequences of co-expression of Kir2.1-D71Y 
with wild-type Kir2.1 (Fig. 2). Co-expression of the wild-type 
and mutant subunits in a 1:1 ratio resulted in significantly 
smaller currents (Fig. 2D) compared to expression of the same 
amount of the wild-type subunit alone (Fig. 2C). For exam-
ple, the mean ± SEM inward current density at -120 mV was 
reduced significantly (p = 0.02) from -249.5 ± 50.3 pA/pF 
(n = 21) in cells expressing wild-type Kir2.1 to -121.3 ± 23.5 
pA/pF (n = 22) in cells co-expressing wild-type Kir2.1 and 
Kir2.1-D71Y (Fig. 2E). Similarly, the mean ± SEM outward 
current density at -50 mV was reduced (p = 0.01) from 4.6 ± 
1.3 pA/pF in cells expressing wild-type Kir2.1 to 1.4 ± 0.5 pA/
pF in cells co-expressing wild-type Kir2.1 and Kir2.1-D71Y 
(Fig. 2F). Co-expression of Kir2.1-D71Y with wild-type Kir2.1 
also resulted in a small depolarizing shift in the resting mem-
brane potential (-46.8 ± 3.0 mV) compared with cells express-
ing only wild-type Kir2.1 (-53.4 ± 1.3 mV), although this trend 
was not statistically significant (p = 0.09). Taken together, these 
observations suggest that Kir2.1-D71Y functions as a domi-
nant negative subunit capable of suppressing the function of 
wild-type Kir2.1 subunits.
identified Kir2.1-D71Y mutation, HEK-293 cells were 
 transiently  transfected with td-tomato together with either wild-
type or mutant KCNJ2 cDNA. Expression of wild-type Kir2.1 
resulted in strongly inwardly rectifying currents in HEK-293 
cells (Fig. 2C) as well as a significant (p < 0.001) hyperpolariza-
tion of the resting membrane potential (mean ± SEM = -53 ± 2 
mV; n = 21) compared to HEK-293 cells expressing td-tomato 
alone (-29 ± 2 mV; n = 9). In contrast, expression of Kir2.1-
D71Y resulted in only small amplitude currents that were indis-
tinguishable from currents present in HEK-293 cells expressing 
td-tomato alone (Fig. 2A); mean ± SEM peak current densities 
at -120 mV in cells expressing td-tomato alone (-8.4 ± 1.4 pA/
pF) or td-tomato plus Kir2.1-D71Y (-6.4 ± 0.5 pA/pF) were not 
significantly different. Expression of either wild-type Kir2.1, 
mutant Kir2.1, or co-expression of wild-type and mutant Kir2.1 
did not result in significant changes in cell membrane capaci-
tance or membrane resistance (data not shown).
Co-expression of Kir2.1-D71Y with wild-type Kir2.1 
results in a reduction of the wild-type current. Because the 
phenotypic manifestations of Andersen-Tawil syndrome are 
evident in heterozygous carriers of KCNJ2 mutations, we next 
Figure 2. Kir2.1-D71Y fails to form functional channels and suppresses wild-type currents in HEK-293 cells. (A–D) Representative whole cell Kir  currents 
recorded in HEK-293 cells expressing td-tomato alone (A), or in the presence of Kir2.1-D71Y (B), wild-type Kir2.1 (C), or both wild-type Kir2.1 and Kir2.1-
D71Y in a 1:1 ratio (D) in response to voltage steps from -120 to -10 mV in 10 mV increments from a holding potential of -70 mV are  illustrated. The cur-
rents were normalized to cell capacitance (in the same cell) and current densities are plotted; the dotted line indicates 0 pA/pF. (E and F) Current-volt-
age relationships for the currents measured in HEK-293 cells expressing td-tomato (diamond), Kir2.1-D71Y (triangle), wild-type Kir2.1 (closed squares), 
or wild-type Kir2.1 and Kir2.1-D71Y in a 1:1 ratio (open squares) are plotted. The voltage range marked by the dashed rectangle in (E) is expanded in (F). 
All values are means ± SEM. Current densities in cells co-expressing wild-type Kir2.1 and Kir2.1-D71Y were significantly (*p < 0.05) lower than in cells 




containing one or more mutant subunits are non-functional and 
the functional channels are entirely wild type (see Discussion).
Dominant-negative suppression of currents requires 
co-assembly of mutant and wild-type subunits. It has pre-
viously been shown that Kir2.1 subunits assemble as tetra-
mers.1 Subsequent experiments here, therefore, were aimed at 
 determining the minimal number of mutant subunits necessary 
to suppress channel function by co-transfecting HEK-293 cells 
with wild-type and mutant subunits in varying proportions. 
Theoretical curves were constructed to predict the expected 
current for each wild-type:mutant subunit ratio based on the 
assumptions that: (1) the proportions of wild-type and mutant 
subunit proteins in each cell reflects the relative proportion of 
the transfected wild-type and mutant cDNA constructs and (2) 
the probability of incorporation of a mutant subunit into a chan-
nel is equivalent to the proportion of mutant subunits expressed 
in the cell. A separate theoretical curve was generated for the 
scenarios in which 1, 2, 3 or 4 mutant subunits are required to 
reduce channel function. As shown in Figure 4, the experimental 
data deviate significantly from the curve predicted for only one 
mutant subunit being required to eliminate channel function, 
suggesting that more than one mutant subunit per channel com-
plex is required to reduce channel function.
Membrane trafficking of Kir2.1-D71Y containing channels. 
One possible mechanism to account for the observed decrease 
in K+ currents when the Kir2.1-D71Y mutant subunit is co-
expressed with the wild-type subunit (Fig. 2) is that there is 
reduced membrane trafficking of wild-type:mutant Kir2.1 mul-
timers compared with wild-type Kir2.1 homomeric channels.10 
To examine the membrane trafficking of Kir2.1-containing 
channels directly, tagged subunits were constructed as described 
in Methods. Briefly, an in-frame C-terminal YFP tag was added 
to the Kir2.1-D71Y subunit and an in-frame C-terminal myc tag 
was added to the wild-type Kir2.1 subunit; both constructs were 
expressed in HEK-293 cells. Similar to the untagged wild-type 
Kir2.1 subunits, expression of Kir2.1-myc subunits resulted in 
robust inwardly rectifying currents (Fig. 5A) whereas expression 
of tagged Kir2.1-D71Y-YFP failed to result in any measureable 
Kir2.1-D71Y does not alter current kinetics. One possible 
mechanism by which mutant subunit co-assembly with wild-type 
subunits could result in decreased currents might be by increas-
ing the binding affinity for one or more of the cytoplasmic agents 
(polyamines and magnesium) responsible for blocking outward 
currents through Kir2.1 channels.1 To explore this possibility, the 
activation phases of the inward currents at hyperpolarized poten-
tials, which reflect the unbinding of magnesium and polyamin s 
from the pore,11 were examined. Analyses of the time course of 
inward current activation revealed an essentially instantaneous 
phase followed by a slower phase that was well-described by a 
single exponential; there were no improvement in the fits when 
multiple exponential terms were included. The amplitude of the 
instantaneous phase represented approximately 70% of the peak 
current for both wild-type (72 ± 1%, n = 20) and wild-type: 
D71Y heteromeric channels (74 ± 2%); these values are not sig-
nificantly different. The time course of the slower phase of activa-
tion is voltage dependent as previously described in reference 11, 
and the activation time constants were indistinguishable for 
wild-type and wild-type:D71Y currents (Fig. 3A). The mean ± 
SEM activation tau at -120 mV, for example, was 0.44 ± 0.03 ms 
in cells expressing wild-type Kir2.1 and 0.40 ± 0.02 ms in cells 
co-expressing wild-type and D71Y Kir2.1 (Fig. 3A).
Kir2.1 mediated currents also exhibit partial inactivation, 
as evidenced by the attenuation of current from the initial peak 
to a steady state plateau during a voltage step and, as previously 
described in reference 12, the extent of the inactivation is voltage 
dependent (Fig. 2C). Fractional current inactivation was quanti-
fied here by calculating the ratio of the peak current to the steady 
state current. There were no significant differences between the 
fractional inactivation of wild-type Kir2.1 and wild-type Kir2.1 + 
Kir2.1-D71Y currents at any test potential (Fig. 3B). At -120 mV, 
for example, the percent current inactivation during the 350 ms 
voltage step was 22 ± 1% for wild-type Kir2.1 (n = 20) and 23 
± 1% for wild-type Kir2.1 + Kir2.1-D71Y (n = 22). Together, 
these observations demonstrate that I
K1
 in the presence of Kir2.1-
D71Y exhibits normal current kinetics; reflecting either that the 
mutant subunits do not alter channel kinetics or that channels 
Figure 3. Voltage-dependent activation and inactivation of currents produced by co-expression of wild-type Kir2.1 and Kir2.1-D71Y are 
 indistinguishable from currents produced by expression of wild-type Kir2.1 alone. (A) The time course of inward current activation was fitted with 
a single exponential and the mean ± SEM time constants (tau) are plotted as a function of membrane voltage. (B) Mean ± SEM percent inactivation 
determined at each voltage are plotted as a function of test potential.
©2011 Landes Bioscience.
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One possibility is that cha ges in I
K1
 might affect the action 
potential threshold and thus contribute to the increase in ventric-
ular ectopy, which occurs in Andersen-Tawil patients. Figure 7B 
shows the amplitude-duration curve for stimuli which result in 
triggered action potentials; only a trivial reduction in rheobase 
(39 vs. 40 pA/pF) resulted from a 90% decrease in I
K1
 amplitude. 
However, subthreshold stimulations resulted in a significantly 
longer depolarization before the membrane voltage returned to 
the resting level when I
K1
 levels were reduced. Figure 7C shows 
illustrative examples in which a 90% reduction in I
K1
 results in 
prolonged depolarizations in response to subthreshold stimuli. 
Similar changes of a smaller magnitude were observed after a 
50% reduction in I
K1
 amplitude (data not shown). In the context 
of an intact heart, these depolarizations could increase the likeli-
hood that a simultaneous, sub-threshold second stimulus would 
generate an action potential and thus offer an explanation of the 
prevalence of ectopic beats observed in patients with Andersen-
Tawil syndrome.
Discussion
With the proliferation of disease associated mutations, it is 
becoming increasingly important to determine whether an iden-
tified genetic variant is pathologic or represents background 
genetic noise.15 The results reported here support the conclu-
sion that the novel KCNJ2-G211T genetic variant identified 
in a patient with Andersen-Tawil syndrome is a loss of func-
tion mutation responsible for the patient’s disease. Experiments 
conducted in heterologous cells revealed that the Kir2.1-D71Y 
mutant subunit co-assembles with wild-type Kir2.1 subunits 
and suppresses currents without detectable effects on membrane 
currents (Fig. 5C). Co-expression of Kir2.1-myc subunits with 
untagged Kir2.1-D71Y subunits resulted in a suppression of the 
current as was seen with untagged subunits (Fig. 5B). The mean 
± SEM peak current density at -120 mV was -598.2 ± 111.7 pA/
pF (n = 11) in cells expressing Kir2.1-myc and -239.6 ± 45.5 pA/
pF in cells co-expressing Kir2.1-myc and Kir2.1-D71Y (p = 0.02). 
Staining of cells expressing the wild-type Kir2.1-myc subunit 
revealed anti-myc staining at the cell surface (Fig. 5D). In addi-
tion, the anti-myc staining was also present in cells co-expressing 
wild-type Kir2.1-myc and Kir2.1-D71Y (Fig. 5E), demonstrating 
that membrane localization of wild-type Kir2.1 subunits persists 
despite the marked reduction of currents in cells co-expressing 
the dominant negative Kir2.1-D71Y subunit. Interestingly, in 
cells expressing YFP-tagged Kir2.1-D71Y subunit, YFP fluores-
cence was evident at the cell surface despite the lack of detectable 
currents (Fig. 5F). These results clearly suggest that the decrease 
in Kir2.1-mediated currents does not result from mislocalization 
of the Kir (wild-type or D71Y mutant) subunits.
Suppression of native IK1 in mouse neonatal cardiomyocytes. 
Ion channel function reflects the interactions of multiple pore-
forming and accessory subunits as well as signaling cascades, 
many of which remain incompletely characterized.13 However, 
these modulatory components are often lacking in non-excitable 
heterologous cell systems such as HEK-293 cells. To explore the 
physiological relevance of our observations in HEK-293 cells, we 
utilized mouse neonatal cardiomyocytes that express a native I
K1
 
composed of Kir2.1 and Kir2.2.4 Transfection of isolated neonatal 
cardiomyocytes with td-tomato and the human KCNJ2-G211T 
cDNA construct resulted in a marked decrease in I
K1
 density 
compared to cells transfected with td-tomato alone (Fig. 6). The 
mean ± SEM peak inward current density at -120 mV was -3.3 
± 0.5 pA/pF (n = 15) in cells expressing Kir2.1-D71Y compared 
to -8.7 ± 3.3 pA/pF (n = 23) in cells expressing td-tomato alone 
(p < 0.0001). The Kir2.1-D71Y mutation, therefore, functions 
as a dominant negative mutation in an intact cellular context. 
Interestingly, despite the decrease in I
K1
, the resting membrane 
potential remained unchanged (-41 ± 2 mV in cells expressing 
Kir2.1-D71Y compared to -43 ± 2 mV in cells expressing td-
tomato, p = NS).
Simulations predict the effects of IK1 reduction in human 
ventricular myocytes. To determine the functional consequences 
of I
K1
 reduction in human cardiac myocytes, we utilized a recently 
published model which accurately reproduces the normal reper-
toire of ionic currents and behavior of the human ventricular 
myocyte.14 As discussed above, the residual current in the pres-
ence of Kir2.1-D71Y exhibits normal kinetic features; therefore, 
I
K1
 kinetics in the model were not changed and the peak current 
amplitude was scaled to reproduce the effects of the Kir2.1 muta-
tions. Reduction of I
K1
 amplitude resulted in action potential 
prolongation; notably, this prolongation was confined to the ter-
minal portion of the action potential (Fig. 7A and Table 1). For 
example, 50% reduction of I
K1
 resulted in no significant changes 
in APD30 or APD50 whereas APD90 was prolonged by 5% and 
APD99 by 13% (Table 1). In addition, no change in resting 
membrane potential or action potential amplitude occurred with 
reduction of I
K1
 amplitude (Table 1).
Figure 4. Wild-type and D71Y Kir2.1 subunits co-assemble in a complex 
requiring at least 2 mutant subunits to reduce wild-type channel 
 function. Theoretical curves (solid symbols) were constructed  predicting 
the current resulting from a given percentage of wild-type subunits 
under the assumption that 1, 2, 3 or 4 D71Y subunits are required to 
reduce channel function. Recorded currents, resulting from varying the 
percentage of wild-type subunits (50% WT, n = 11; 60% WT, n = 7; 70% 
WT, n = 7; 80% WT, n = 9; WT, n = 8), are superimposed in open circles. All 




trafficking of channel subunits or current  kinetics. 
Additional experiments demonstrated that the 
human Kir2.1-D71Y subunit suppresses native I
K1
 
in mouse  neonatal cardiomyocytes, providing fur-
ther support that this mutation results in I
K1
 chan-
nel dysfunction in vivo. Simulations predict that 
in the context of the human ventricular myocyte, 
this mutation will result in action potential pro-
longation and no change in the resting membrane 
potential but a decreased stability of the mem-
brane voltage resulting in prolonged sub-threshold 
depolarizations.
Physiological roles of Kir2.1. There is general 
consensus that Kir2.1 plays important roles in 
regulating the electrical excitability of both cardiac 
and skeletal muscle, although several previous stud-
ies have provided conflicting results regarding the 
role of Kir2.1 mediated currents in the generation 
of cardiomyocyte resting membrane potentials.4,16 
The results of the experiments completed here, how-
ever, demonstrated that neither the co-expression 
Figure 5. Both mutant and wild-type Kir2.1 subunits localize to the cell surface in HEK-293 cells. Representative whole cell currents recorded from 
HEK-293 cells expressing td-tomato with Kir2.1-myc (A), Kir2.1-myc + Kir2.1-D71Y (B) or Kir2.1-D71Y-YFP (C) in response to voltage steps from -120 mV to 
-10 mV (10 mV increments) from a holding potential of -70 mV were normalized to cell capacitance and plotted; the dotted line indicates 0 pA/pF. (D) In 
cells expressing wild-type Kir2.1-myc alone, anti-myc staining is evident at the cell surface. (E) Anti-myc staining is also evident at the cell surface when 
wild-type Kir2.1-myc was co-expressed with the mutant Kir2.1-D71Y. (F) When expressed alone, the mutant Kir2.1-D71Y-YFP subunit is also evident 
at the cell surface. For all parts, the (wild-type or mutant) Kir2.1 subunit staining contrasts with the cytoplasmic td-tomato fluorescence. Scale bar 
= 60 μm.
Figure 6. Native IK1 in neonatal mouse ventricular myocytes is suppressed by 
 expression of Kir2.1-D71Y. (A and B) Representative Kir currents recorded from mouse 
neonatal myocytes transfected with td-tomato alone (A) and in the presence of human 
Kir2.1-D71Y (B) in response to voltage steps from -120 mV to -40 mV in 10 mV increments 
from a holding potential of -70 mV and normalized to cell capacitance. (C) Mean ± SEM 
peak native IK1 density measured at -120 mV in cells transfected with td-tomato alone 
(solid bar) and in the presence of human Kir2.1-D71Y (open bar).
©2011 Landes Bioscience.
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Despite the lack of effect on resting membrane potential, I
K1
 
could play a role in membrane stability and excitability. Due to 
the fact that cellular excitability depends on the aggregate effects 
of an array of species-specific ion channels, an in silico model of 
the human ventricular myocyte was used to explore the role of 
I
K1
 in membrane stability. Interestingly, simulation results indi-
cated that I
K1
 plays an important role in the rate at which the 
membrane returns to the resting potential after a perturbation. 
of wild-type and mutant Kir2.1 subunits in HEK-293 cells nor 
the expression of the mutant Kir2.1-D71Y in mouse neonatal 
cardiomyocytes resulted in a significant change in resting mem-
brane potential despite suppressing Kir2.1 mediated currents. In 
conjunction with modeling data failing to predict a change in 
human cardiomyocyte resting membrane potential, these results 
suggest that the KCNJ2-G211T mutation likely does not exert its 
pathologic effects via a change in resting membrane potential.
Figure 7. Human ventricular myocyte simulations. (A) The simulated steady-state action potential in wild-type cells (heavy line) is shown with a family 
of superimposed action potentials (light lines) predicted to result from progressive decreases in IK1 amplitude in 10% increments. (B) Amplitude-
duration relationship for triggered action potentials is shown for wild-type (solid symbols and line) and cells with a 90% decrease in IK1 amplitude 
(open symbols and dotted line). (C) Membrane potential response to stimuli of varying amplitude (as indicated in each part) in both wild-type cells 
(solid line) and cells with 90% reduction in IK1 (dotted line) demonstrating both a small change in action potential threshold and prolonged membrane 






 affinity,19 a mutation in the slide helix has been shown 
to alter both magnesium and PIP
2
 sensitivity,20 and mutations 
in multiple regions have been associated with altered membrane 
localization.10,21 Interestingly, additional mutations located in 
the slide helix region have been shown to function as dominant 
negative loss of function mutations without affecting membrane 
localization or PIP
2
 binding affinity.9 Similar to several previously 
reported mutations,9 the D71Y mutation reported here is located 
in the slide helix region of the Kir2.1 (Fig. 1B) and does not 
affect membrane localization. In addition, we report here that 
the presence of D71Y mutation has no effect on current kinetics, 
indicating that either this region does not directly participate in 
channel gating or that this mutation renders the channel entirely 
non-functional, thus leaving a (normal) residual current com-
posed of solely wild-type subunits.
Methods
cDNA constructs. A cDNA encoding human KCNJ2 was 
obtained from Open Biosystems and a PCR product contain-
ing the open reading frame with added EcoR1 and Xho1 sites 
was subcloned into the mammalian expression vector pCMV 
Script (Clontech). PCR site-directed mutagenesis was carried 
out using the QuickChange XL kit (Stratagene); the mutated 
gene was subcloned into pCMV Script and the final construct 
was sequenced to verify the mutation and to exclude PCR errors. 
In addition, the KCNJ2 cDNA was subcloned into pCMV 
c-myc (Clontech) and the KCNJ2-G211T cDNA was subcloned 
into pEYFP-N1 (Clontech) to generate myc- and YFP-tagged 
 subunits, respectively.
Cell culture and transfections. Human embryonic kidney-293 
(HEK-293) cells were maintained in Dulbecco’s Modified Eagle 
Medium (DMEM-Gibco, Invitrogen, 11965) supplemented with 
5% fetal bovine serum (Atlas Biological, FP-0500-A), 5% horse 
serum (Gibco, Invitrogen, 26050), and penicillin/streptomycin 
(Gibco, Invitrogen, 15140) in a 37°C 95% air/5% CO
2
 incuba-
tor. Mouse neonatal cardiomyocytes were isolated from post-natal 
day 1–3 pups anesthetized with isoflurane and euthanized by 
decapitation. After removing the hearts, ventricles were dissected 
and minced in Hanks Balanced Salt Solution (HBSS), contain-
ing in mM: 127 NaCl (Sigma, S5886), 5.4 KCl (Sigma, P9541), 
4.2 NaHCO
3









 (Sigma, P5655), 5.5 glucose (Sigma, G6152), and 
penicillin/streptomycin. The ventricular pieces were incubated 
overnight in HBSS containing 0.1% trypsin (T8003, Sigma) fol-
lowed by a 30 min incubation at 37°C. The tissue was triturated, 
centrifuged at 300x g, and resuspended in DMEM supplemented 
with 20% fetal calf serum and penicillin/streptomycin. Cells 
were plated on tissue culture plates for 1 h at 37°C to allow adhe-
sion of fibroblasts. Cells in suspension were then plated on colla-
gen (type 1, Sigma, C9791)-coated coverslips at low density and 
transfected after 24 h incubation at 37°C.
Transient transfections were carried out using Lipofectamine 
2000 (Invitrogen) as previously described in reference 22. All 
transfections were performed with 1 μg of wild-type vector, 
variable amounts of mutant vectors, and variable amounts of 
Sub-threshold stimuli resulted in a prolonged depolarization in 
the setting of I
K1
 reduction. This finding suggests a novel mecha-
nism by which I
K1
 reduction contributes to arrhythmias, i.e., by 
generating sub-threshold depolarizations that could summate to 
result in ectopic activation.
Inwardly rectifying K+ currents have also been suggested to 
play an important role in the repolarization phase of the action 
potential and in the stability of ventricular arrhythmias.3 Previous 
studies using either knock-out or dominant-negative strategi s 
in mice and guinea pig have demonstrated action potential pro-
longation.4,16,17 In this study, the human cardiac myocyte model 
predicted action potential prolongation confined to the terminal 
portion of the action potential. This finding is consistent with 
published results on guinea pig cardiomyocytes but contrasts 
with studies of mouse cardiomyocytes which exhibited action 
potential prolongation at both APD50 and APD90.4,17 These 
observations emphasize the potentially species-specific nature of 
electrophysiological perturbations reflecting differences in ion 
channel expression and function.
Kir2.1, as well as many related Kir family members, is expressed 
in a wide variety of tissues, a fact that is consistent with the clini-
cal observations that patients harboring mutations in KCNJ2 
exhibit a complex phenotype affecting multiple tissues.2 The 
patient carrying this KCNJ-G211T2 mutation suffered periodic 
paralysis, cardiac ectopy and skeletal abnormalities consistent 
with a role for Kir2.1 channels in the function of skeletal muscle, 
cardiac  myocytes and bone development. It has been shown that 
inward rectifying currents are present in osteoclasts where they 
are believed to offset the hyperpolarization induced by proton 
export.2 In addition to its role in electrical excitability, Kir2.1 
expression in skeletal muscle is involved in myotube fusion.2
Kir2.1 structure and function. Andersen-Tawil syndrome 
associated mutations have been reported throughout the sequence 
of KCNJ2, including the transmembrane helices, the ion selectiv-
ity filter, the slide-helix and the N- and C-termini.18 Most of the 
identified Andersen-Tawil syndrome associated mutations result 
in dominant-negative suppression of wild-type Kir2.1-mediated 
currents through multiple mechanisms. Previous KCNJ2 muta-
tions located in the PIP
2
 binding domain have been shown to 
Table 1. Simulated action potential parameters resulting from IK1  






Resting Vm (mV) -88 -88 -89
Action potential amplitude 
(mV)
128 128 130
APD30 (ms) 165 164 164
APD50 (ms) 207 206 207
APD90 (ms) 266 278 304
APD99 (ms) 286 322 552
No significant change occurred in resting membrant potential (Vm), 
 action 
potential amplitude, or action potential duration measured at 30% or 
50% repolarization (APD30 and APD50) whereas action potential  duration 
at 90% and 99% repolarization (APD90 and APD99) was  prolonged.
©2011 Landes Bioscience.
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= probability that a channel contains k mutant subunits, 
n = total number of subunits, k = number of mutant subunits and 
p = probability of incorporation of a mutant subunit (assumed 
to be equal to the proportion of transfected mutant cDNA). 
Assuming that the decrease in current is proportional to the per-
centage of dysfunctional channels, this allows the generation of 
a family of theoretical curves predicting the decrease in current 
based on the hypotheses that one, two, three or four mutant sub-
units are required to reduce channel function. The current result-
ing from different ratios of wild-type and mutant subunits is then 
recorded and the data fit to the best theoretical curve.
Simulations. Simulations were carried out using a model of 
human endocardial ventricular myocytes using the published 
O’Hara-Rudy dynamic model14 with the addition of a scaling 
factor to reduce I
K1
 amplitude. All simulations were carried out 
for 1,000 beats to ensure steady state conditions. Amplitude-
duration curves were constructed by determining the minimal 
stimulus amplitude required to trigger an action potential for 
each stimulus duration; the resulting curve was fitted with a sin-
gle exponential function, using Prism to determine the rheobase.
Conclusion
In summary, the experiments presented here demonstrate that 
a novel G211T mutation in KCNJ2 identified in a patient with 
all of the cardinal features of Andersen-Tawil syndrome results 
in the production of mutant Kir2.1-D71Y protein that functions 
as a dominant negative to suppress endogenous I
K1
. The mutant 
subunit reduces wild-type Kir2.1 currents in both HEK-293 cells 
and neonatal mouse cardiomyocytes, without measureable effects 
on membrane localization, current kinetics or resting membrane 
potentials. Simulations predict that these effects would lead to 
a prolongation of the human cardiomyocyte action potential 
and to destabilization of the resting membrane potential. These 
observations are interpreted as suggesting that this mutation is 
responsible for the patient’s clinical syndrome.
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Whole-cell recordings. Twenty-four to 36 h (for HEK-
293 cells) or 24–48 h (for neonatal myocytes) after transfec-
tion, whole-cell K+ currents were recorded at room temperature 
(20–23°C) using previously described solutions and proto-
cols.22,23 Recording pipettes fashioned from borosilicate glass 
(WPI, TW150F-4) had resistances of 2–3 MΩ when filled with 
recording solution. Experiments were controlled by and data 
were collected using an Axopatch 1D, digitized with a Digidata 
1322A and stored on a Gateway PC running Clampex 9.2 
(all Molecular Devices).
Data analysis. Data were analyzed using ClampFit 
(Molecular Devices), Excel (Microsoft) and Prism (GraphPad). 
Only cells with a membrane resistance >300 MΩ and an access 
resistance <15 MΩ were analyzed. Membrane capacitance 
and input resistance were measured by analyzing the decay 
phases of the capacitive current elicited by a 20 ms voltage step 
(±10 mV) from a holding potential of -40 mV, as described previ-
ously in reference 23. Peak Kir currents were measured by aver-
aging the current during 10 ms at the maximal current evoked 
at each test potential. Steady state Kir currents were measured 
340 ms after the onset of the voltage steps. Instantaneous Kir 
currents were measured at the end of the initial capacitive tran-
sient. The time course of current activation was determined by 
fitting the current trace from the end of the capacitive tran-
sients to the peak current with a mono-exponential function. 
All data were tested for normalcy and subsequently analyzed 
with a one- or two-way ANOVA, Kruskal-Wallis, unpaired 
t-test or Mann-Whitney U test as appropriate. All results are 
reported as means ± SEM.
Immunohistochemistry. Thirty-six hours after transfections, 
HEK-293 cells were washed in phosphate buffered saline (PBS) 
and fixed with 4% paraformaldehyde for 20 min. Cells were 
incubated for 1 h in blocking buffer (PBS with 5% goat serum 
and 0.2% Triton X-100) followed by incubations with primary 
and secondary antibodies [1:1,000 mouse anti-myc monoclonal 
antibody (Millipore), 1:1,000 Alexa 488 goat anti-mouse anti-
body (Invitrogen)] in blocking buffer for 1–2 h each at room 
temperature. After washing in PBS, coverslips were mounted 
in ProLong Gold antifade solution (Invitrogen). Cells were 
imaged on a Nikon Eclipse inverted microscope equipped with 
a CoolSNAP CCD (Photometrics); images were acquired using 
Volocity 4 (Improvision, PerkinElmer) software.
Calculation of channel stochiometry. The number of mutant 
subunits required to reduce channel function was estimated 
using previously described methods in reference 24. Briefly, the 
 distribution of possible combinations of four subunits, each of 
which can be either wild-type or mutant, follows a binomial 
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